ONC
BeOne Medicines Ltd.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$358.26
−1.22%Margins
Gross margin
88.9%
EBITDA margin
18.9%
EBIT margin
15.1%
Net margin
10.7%
FCF margin
20.3%
12.7%
Return on equity
7.1%
Return on assets
14.6%
Return on invested capital
0.69x
Asset turnover
$1.7B
Cash from operations
$45
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026